The global emergence of methicillin-resistant Staphylococcus aureus (MRSA) has turned into a serious public health problem. The bacterium is known as the most significant cause of nosocomial infections, which are resistant to different antibacterial classes. Antibiotic therapy has faced severe difficulties due to these strains (David et al., 2006 and Holmes et al., 2005) .
The pathogenesis of S. aureus is caused by several virulence factors such as staphylococcal exoproteins (Gravet et al., 1998) . Among the exotoxins produced by S. aureus, some can selectively destroy phagocyte cells such as polymorphonuclear cells and monocytes. These exotoxins belong to the bi-component leukotoxin family, including S and F proteins. Panton-Valentine leukocidin (PVL) is a member of the staphylococcus leukotoxin family (Choorit et al., 1995; Kaneko et al., 1997 and Havaei et al., 2010) . It is a very important virulence factor in S. aureus, which is a pore-forming exotoxin and its toxic effects result from the synergistic performance of 2 separate proteins (LUK S-PV and LUK F-PV) Ruimy et al., 2008) .
Staphylococcus aureus strains containing the PVL gene have the potential to epidemiologically spread in the community (Hollis et al., 1995) . In fact, the PVL gene was first reported among community-acquired (CA) MRSA strains (Miller et al., 2005) .
CA-MRSA strains are more likely to produce PVL , but some studies refer to the prevalence of PVL-containing S. aureus isolates from the community to the hospital (O'Brien et al., 1999) , this is a remarkable risk to public health. Moreover, the analysis of MRSA isolates in Holland (2003) showed that 8% of nosocomial isolates carry locus for PVL (Wannet et al., 2004) . Therefore, the isolates do not only exist in communities but can also spread in hospitals (Wagenlehner et al., 2007) . Consequently, early diagnosis and decolonizing carriers is inevitable and essential, since it can prevent person-to-person transmission of the isolates and, ultimately, fatal prevalence (Munckhof et al., 2009 ).
In the current study, the prevalence of PVL gene was determined using PCR technique among S. aureus isolated from clinical samples in two Egyptian hospitals. The isolates were identified as MRSA or MSSA.
Material and Methods

Patient and sampling
The samples were collected from out patients and inpatients departments, (Intensive Care Unit, orthopedic) at Zagazig University hospitals, Egypt and from Kobbri El-Kobba Military Hospital in Cairo. The samples collected from January 2010 to December 2010. These cases were suffering urinary tract infection, cutaneous abscesses, wounds infection, pneumonia, furunculosis and several necrotic infections. These samples included mainly pus, urine, blood and sputum.
Bacterial cultivation and isolation
The collected samples were cultivated on Blood agar, Deoxyribonuclease, Mannitol salt agar and Meuller Hinton agar.
Bacterial Identification
A. Morphology and microscopy: Colonies were examined for morphology and Gram positive grape-like clusters of staphylococci (Kloos and Bannerman, 1995 
Chrom ID MRSA
The bacterial isolates were subjected to culture on a chromogenic media for detection of MRSA.
Multiplex polymerase chain reaction (PCR)
The primers (GeneBank accession no. AB245454) were designed according to Taneike et al. (2006) and Motoshima et al. (2010) . The primer for the luk-PV gene that encoding Panton-Valentine Leucocidin is the forward primer GTG ATC GCG CTG AGG TAG TG and the reverse primer CCT CCT GTT GAT GGA CCA CT. PCR reaction was performed according to the following steps:
A. Dream Taq Green PCR Master Mix (2x) was gently vortexed and briefly centrifuged after throwing. B. A thin-walled PCR tube was placed on ice and the following components were added for each 50µl reaction: E. Five µl of PCR product was loaded directly on agarose gel using DNA Ladder. (Taneike et al., 2006) .
Statistical analysis
Data analysis was performed using Chi-squared test, Fisher's exact test and T-test. Table 1 . shows the distribution of MRSA and MSSA among different types of specimens with no statistically significant difference.
Results
Five out of 8 PVL carrying S. aureus isolates were MRSA and ten non S. aureus isolates were negative for the PVL gene, 3 of them were coagulase negative Staphylococci. The prevalence of the PVL gene among MRSA and MSSA isolates (Table 2 ) and different age of patients (Table 3) , shows no significant difference. On the other hand among the 8 PVL strains, 7 were isolated from males, none from females and 1 without recovered gender, revealing a significant differnce (Table 6 ). The type of sample shows no statistical association with the detection of the PVL gene in the isolated S. aureus strains (Table 4) . However, 5 out of 8 PVL carrying isolates were from pus samples. Among the 8 PVL gene carrying strains, there were five isolates from different wounds or abscesses, one from blood infection and one from lung infection (pleural fluid) (Table 5) . (Genestier et al., 2005) . Although produced by < 5% of S. aureus strains according to some studies, the toxin is detected in large percentages of isolates that cause necrotic skin lesions and severe necrotizing pneumonia (Lina et al., 1999) . It is commonly associated with community-acquired methicillin resistant S. aureus (CA-MRSA) (Vandenesch et al., 2003) . However, several outbreaks due to methicillin susceptible S. aureus (MSSA) have also been reported (Boubaker et al., 2004 ; Österlund et al., 2002 and Le Thomas et al., 2001 ).
Discussion
Panton-Valentine leukocidin (PVL) is a cytotoxin produced by Staphylococcus aureus that causes leukocyte destruction and tissue necrosis
The prevalence of the PVL gene among MRSA, MSSA and all S. aureus isolated in this study, showed similar percentages (around 12%). This agreed with a study reporting that the rate of MSSA harboring the PVL gene was (11.3%) (Shallcross et al., 2009) . While, the prevalence of the PVL gene is estimated to be some 2-35% among MRSA strains as previously reported by other studies (Santucci et al., 2003 and Melles et al., 2004) . Previous reports indicated that PVL is produced by < 5% of S. aureus strains (Lina et al., 1999) . On the other hand, Azar et al. )2012( showed that the prevalence of the PVL gene in MRSA strains was (7.23%), while this prevalence was (33.3%) for in MSSA strains. Another study shows that the prevalence of PVL-positive MRSA was 10.7% and among PVL-positive isolates 75% were MRSA (6 MRSA out of 8 PVL-positive) (Solmaz et al., 2012) , which is close to our study as 5 out of 8 PVL positive isolates were MRSA (63%). A recent Indonesian study reported that 1.5% of the studied patients carried Panton-Valentine leukocidin (PVL)-positive methicillin-sensitive S. aureus (MSSA) (Santosaningsih et al., 2014) .
However, the differences in the rate of prevalence are possibly due to different geographical areas and the type of assay used to diagnose the gene.
The age of patients had no significant effect on the prevalence of PVL according to the current study. Similarly, data analysis of Azar et al. (2012) who studied isolates from burns, revealed that there was no significant correlation between the presences of genes mecA, PVL and patients' age or degree of burn (P> 0.5). Lopez-Aguilar et al. (2007) also showed no significant effect of patient age. However, Shallcross et al. (2010) reported that compared to individuals aged <20 years, the odds of PVL-SA-related infection were highest in subjects aged 20-39 years and reduced thereafter with increasing age (OR 3.2, 95% CI 1.1-8.7, p 0.02).
On the other hand the 7 PVL isolates in this study were from males and not from females and 1 without recorded gender with a statistically significant difference. The higher prevalence of PVL in isolates from males is not clearly explained but the relative activity of males and possible exposure to different types of injuries and community infections may provide a possible explanation especially since most of these isolates were from wounds. Although, LopezAguilar et al. (2007) showed no statistically significant effect of patient gender, the 5 PVL positive isolates were exclusively from males while PVL negative isolates were 12 were males and 7 were from females. On the other hand Shallcross et al. (2010) showed that men had approximately twice the odds compared to women of having PVL-S. aureus-related disease.
The type of sample shows no statistical association with detection of the PVL gene in the isolated S. aureus strains. However, 5 out of 8 PVL carrying isolates were from pus samples. Among the 8 PVL gene carrying strains, there were five isolates from different wounds or abscesses, one from blood infection and one from lung infection (Pleural fluid). Gerard et al. (1999) reported that a collection of 172 S. aureus strains were screened for PVL genes by polymerase chain reaction amplification. PVL genes were detected in 93% of strains associated with furunculosis and in 85% of those associated with severe necrotic hemorrhagic pneumonia (all community-acquired). They were detected in 55% of cellulitis strains, 50% of cutaneous abscess strains, 23% of osteomyelitis strains, and 13% of fingerpulp-infection strains. PVL genes were not detected in strains responsible for other infections, such as infective endocarditis, mediastinitis, hospital-acquired pneumonia, urinary tract infection, and enterocolitis, or in those associated with toxic-shock syndrome. It thus appears that PVL is mainly associated with necrotic lesions involving the skin or mucosa. Solmaz et al. (2012) reported that out of 56 isolates, 14.3% were PVL positive with 37.5% were from abscess and 62.5% from wound. Among all of these isolates 67.8% were MRSA.
It is noted in various reports that a patient with abscess or recurrent furuncle should be primarily suspected of PVL related S. aureus infection (Department of health, 2007). Shallcross et al. (2010) showed that PVL-SA infection was strongly associated with skin and soft tissue disease and these samples were four-fold more likely to contain the PVL genes compared to all other sample types. Didisheim et al. (2014) reported 3 cases of osteoarticular infections by S. aureus PVL positive sensitive to methicilline, which illustrates the difficulties encountered in the management and treatment, as well as the potential for serious orthopedical complications.
Accurate and rapid detection of methicillin-resistant Staphylococcus aureus is very important in a clinical laboratory setting to avoid treatment failure. Velasco et al. (2005) stated that in the absence of availability of molecular biology techniques, the cefoxitin disc was the best predictor of methicillin resistance in S. aureus among the techniques tested. Other authors also reported that the results of cefoxitin disc diffusion test one in concordance with the PCR for mecA gene and give better results compared to the oxacillin disc diffusion method. Thus, cefoxitin disc diffusion test can be an alternative to PCR for detection of MRSA in resource constraint settings (Anand et al., 2009) . However, Adaleti et al. (2008) compared conventional methods (oxacillin agar screening (OAS), oxacillin disc diffusion (ODD) and cefoxitin disc diffusion (CDD) methods) against the gold standard polymerase chain reaction (PCR) technique to determine the best combination of the routine procedures. They concluded that combining the ODD and CDD methods could be a good choice for detecting methicillin resistance in S. aureus strains where mecA PCR cannot be performed. By consideration of this report, combining the ODD and CDD methods was used in the current study to identify MRSA strains.
The current study shows that among 42 isolates reported as MRSA by the conventional sensitivity tests (for oxacillin and cefoxitin), only 27 isolates recognized as MRSA by few Chrom ID MRSA test. This figure shows a high were significant difference between the two methods and shows sensitivity and specificity of Chrom ID MRSA of 64.3% and 96% respectively as compared to antibiotic sensitivity methods. These results disagree with other reports by Kumar et al. (2013) who stated that the MRSA ID chromogenic medium has a sensitivity of 96% and a specificity of 99.5% after 24 hr of incubation but it compared to PCR as a gold standard. This variation in specificity may (in addition to the different gold standard reference methods) due to cultivation conditions such as incubation time as Van Vaerenbergh et al. (2010) compared two chromogenic media for the detection of MRSA: BBL CHROMagar MRSA II (BD) and MRSA ID agar (bioMe´rieux). After 24 hr, the sensitivities of both media were high and comparable. Both media showed an important decrease in specificity after 48 hr of incubation (decreases of 8% for MRSA II and 10% for MRSA ID), but MRSA II was significantly more specific at both time points.
PVL-carrying isolates do not only exist in communities but can also spread in hospitals (Wagenlehner et al., 2007) . To counter this emerging global threat to Public health, systematic surveillance of both hospital and community isolates is required, together with measures designed to limit their spread. Consequently, early diagnosis and decolonizing carriers is inevitable and essential, since it can prevent person-to-person transmission of the isolates. In suspected cases, PVL and MRSA detection could be included in one panel for rapid response to the
